ClinicalTrials.gov
public full text
Public Domain
A Study to Determine the Bioequivalence of Two Doses of Tafamidis
Study to characterize the bioequivalence of a 12.2 mg free acid tablets compared to commercial supply (tafamidis meglumine soft gelatin 20 mg capsule) in healthy participants under fasted conditions.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety And Pharmacokinetic Assessment Of Orally Administered Tafamidis In Healthy Volunteers#837505
- Phase I Safety, Pharmacokinetics and Bioavailability Study Comparing Rate and Extent of Absorption of Two Different Forms of Tafamidis (PF-6291826)#829409
- Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fasting Condition#870350
- A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults#1115258
- Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy#847732
Record · ID 1007733
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive